More than a third of US doctors and more than half of US patients are either unable or unwilling to talk about a condition that is rare in the US and that has the potential to disrupt their ability to work or save their lives, according to new research.
The condition, known as Epidemic Epidomegalovirus (E.E.V.), is rare and has no cure.
It affects 1 in 10 people in the country, mostly older adults.
“Epidemic E.E.,” or E.P.V., is a condition where people are infected with the virus and develop fever, cough, runny nose and joint pain.
Most people who get it are in the age group 50 to 64.
But E.D.V. affects the older adults more than other age groups.
“There is a lot of work to do,” said Dr. Daniel Raff, chief medical officer for the American Epidural Society (AES).
“We know that it’s going to take a while to get a lot more people talking about it.”
The condition affects some people as young as 50, but it’s only in the past few years that it has been found in more older people.
Raff said the epidemic has the ability to impact the workforce, but he said it’s not necessarily the main cause of it.
There’s no cure and the best we can hope for is to get it under control,” he said.
The AES, which represents more than 700,000 doctors in the United States, released a report last year showing that one in five doctors were either not aware or unwilling or unable to talk to their patients about their Epidemias.”
I think we are all kind of going to have to figure out what we do with this,” said Raff.
Dr. James Martin, the chair of the American College of Emergency Physicians, said the lack of awareness of the disease has contributed to the situation.”
Martin said the public’s reluctance to get vaccinated has also made it harder for doctors to get on board. “
It’s been a little bit of a muddle.”
Martin said the public’s reluctance to get vaccinated has also made it harder for doctors to get on board.
In recent years, more doctors have been working to educate doctors about E.T.
V, but Martin said it has taken time.
“We have had some good news in the last couple of years, but we still have a long way to go,” he explained.
“So we are working to get more information out there and that’s something that we’re doing.”
Martin has been involved in helping people understand E.S.
V for years.
He has even written a book, “E.T., the Unknown Virus,” about it.
He said it was important for doctors and patients to learn more about the condition.
“They need to understand this condition,” he added.
But the lack, and sometimes confusion, surrounding E.
V is a problem.
Dr. Amy Kupferberg, a professor of emergency medicine at the University of Michigan, said some doctors are simply not willing to get their hands dirty.
“This is not a diagnosis that can be made easily.
We’re not doing this to just get a quick diagnosis, we’re trying to make an informed diagnosis,” Kupfert said.
She said the stigma of E.v. and the lack or inability to treat it can be frustrating for patients.
“In a sense, it is a very scary situation, because it’s really stigmatizing,” she said.
